Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 180 citing Forman: Hepatic failure in a patient taking rosiglitazone. (0.20 sec) 

Drug-induced hepatotoxicity

- uab.edu [PDF] 
WM Lee - The New England journal of medicine, 2003 - nejm.highwire.org
In the past five years, two drugs have been withdrawn from the market by the
Food and Drug Administration (FDA) for causing severe liver injury, a potential
danger that had not been fully recognized in the course of the preapproval ...
Cited by 665 - Related articles - BL Direct - All 22 versions

[PDF] Nonhypoglycemic effects of thiazolidinediones


AA Parulkar, ML Pendergrass, R Granda- … - Ann Intern Med, 2001 - Am Coll Physicians
The thiazolidinediones are a new class of compounds for treat- ment of type 2
diabetes. Troglitazone became available in the United States in 1997 but was
withdrawn from the market in March 2000 because it caused severe ...
Cited by 417 - Related articles - All 4 versions

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis


SH Caldwell, EE Hespenheide, JA Redick, JC … - The American journal of gastroenterology, 2001 - nature.com
Troglitazone is a thiazolidinedione and peroxisome proliferator–activated
receptor gamma (PPAR ) ligand used to treat diabetes mellitus type II. Because
hyperinsulinemia may be a factor in nonalcoholic steatohepatitis (NASH), we ...
Cited by 336 - Related articles - BL Direct - All 7 versions

Metabolic and additional vascular effects of thiazolidinediones

- adisonline.com [PDF] 
F Martens, FLJ Visseren, J Lemay, EJP De … - Drugs, 2002 - ingentaconnect.com
Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . 1464 1. Peroxisome Proliferator-Activated
Receptors (PPARs) . . . . . . . . . . . . . . . . . . . . . . . . . . 1465 ...
Cited by 251 - Related articles - BL Direct - All 9 versions

Thiazolidinediones in type 2 diabetes mellitus: current clinical evidence

- adisonline.com [PDF] 
M Diamant, RJ Heine - Drugs, 2003 - ingentaconnect.com
Abstract. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . 1373 1. Thiazolidinediones: Basic Aspects and Mode of Action ...
Cited by 174 - Related articles - BL Direct - All 9 versions

Drug-induced liver disease


JH Lewis - Medical Clinics of North America, 2000 - Elsevier
A temporal relationship usually is evident with an implicated drug, with most
cases of acute DILD occurring within 1 week to 3 months of exposure. A positive
response to discontinuing the agent (dechallenge) enhances the suspicion, ...
Cited by 158 - Related articles - BL Direct - All 20 versions

Evaluation of liver function in type 2 diabetic patients during clinical trials

- diabetesjournals.org
HE Lebovitz, M Kreider, MI Freed - Diabetes Care, 2002 - Am Diabetes Assoc
OBJECTIVE—Troglitazone treatment has been associated with idiosyncratic
hepatic reaction leading to hepatic failure and death in some patients. This
raises questions regarding whether all thiazolidinediones or peroxisomal ...
Cited by 149 - Related articles - BL Direct - All 8 versions

Glitazones: clinical effects and molecular mechanisms


M Stumvoll, HU Häring - Annals of Medicine, 2002 - informahealthcare.com
With the thiazolidinediones rosiglitazone and pioglitazone a novel treatment
modality for type 2 diabetes has become available in many countries. As
monotherapy, fasting blood glucose and glycosylated hemoglobin (HbA1c), on ...
Cited by 140 - Related articles - BL Direct - All 7 versions

An openlabel trial of the PPAR-g ligand rosiglitazone for active ulcerative colitis


JD Lewis, GR Lichtenstein, RB Stein, JJ … - Am J Gastroenterol, 2001 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 133 - Related articles - BL Direct - All 6 versions

Disorders of glucose metabolism in patients infected with human immunodeficiency virus


MP Dubé, KH Mayer - Clinical infectious diseases, 2000 - UChicago Press
Featured in Reuters-USE_THIS "Dual HIV/TB infection common in S. African
infants" December 29, 2008 # High Incidence of Tuberculosis among HIV-Infected
Infants: Evidence from a South African Population-Based Study Highlights ...
Cited by 130 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google